International Flavors & Fragrances Net Profit Margin 2010-2024 | IFF
Current and historical net profit margin for International Flavors & Fragrances (IFF) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. International Flavors & Fragrances net profit margin for the three months ending September 30, 2024 was .
| International Flavors & Fragrances Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-09-30 |
$11.42B |
$-2.32B |
-20.33% |
| 2024-06-30 |
$11.31B |
$-2.36B |
-20.82% |
| 2024-03-31 |
$11.35B |
$-2.50B |
-22.01% |
| 2023-12-31 |
$11.48B |
$-2.57B |
-22.36% |
| 2023-09-30 |
$11.62B |
$0.02B |
0.15% |
| 2023-06-30 |
$11.86B |
$-2.20B |
-18.58% |
| 2023-03-31 |
$12.24B |
$-2.12B |
-17.35% |
| 2022-12-31 |
$12.44B |
$-1.87B |
-15.04% |
| 2022-09-30 |
$12.63B |
$-1.76B |
-13.91% |
| 2022-06-30 |
$12.64B |
$0.64B |
5.03% |
| 2022-03-31 |
$12.42B |
$0.56B |
4.48% |
| 2021-12-31 |
$11.66B |
$0.27B |
2.32% |
| 2021-09-30 |
$9.90B |
$0.25B |
2.50% |
| 2021-06-30 |
$8.09B |
$0.14B |
1.71% |
| 2021-03-31 |
$6.20B |
$0.20B |
3.18% |
| 2020-12-31 |
$5.08B |
$0.36B |
7.14% |
| 2020-09-30 |
$5.10B |
$0.38B |
7.45% |
| 2020-06-30 |
$5.10B |
$0.42B |
8.28% |
| 2020-03-31 |
$5.19B |
$0.47B |
9.08% |
| 2019-12-31 |
$5.14B |
$0.46B |
8.87% |
| 2019-09-30 |
$5.08B |
$0.39B |
7.59% |
| 2019-06-30 |
$4.72B |
$0.35B |
7.51% |
| 2019-03-31 |
$4.34B |
$0.32B |
7.30% |
| 2018-12-31 |
$3.98B |
$0.34B |
8.47% |
| 2018-09-30 |
$3.61B |
$0.28B |
7.86% |
| 2018-06-30 |
$3.58B |
$0.30B |
8.33% |
| 2018-03-31 |
$3.50B |
$0.31B |
8.82% |
| 2017-12-31 |
$3.40B |
$0.30B |
8.71% |
| 2017-09-30 |
$3.31B |
$0.42B |
12.58% |
| 2017-06-30 |
$3.21B |
$0.40B |
12.33% |
| 2017-03-31 |
$3.16B |
$0.40B |
12.75% |
| 2016-12-31 |
$3.12B |
$0.41B |
13.03% |
| 2016-09-30 |
$3.07B |
$0.41B |
13.20% |
| 2016-06-30 |
$3.06B |
$0.42B |
13.77% |
| 2016-03-31 |
$3.03B |
$0.41B |
13.49% |
| 2015-12-31 |
$3.02B |
$0.42B |
13.82% |
| 2015-09-30 |
$3.06B |
$0.43B |
14.00% |
| 2015-06-30 |
$3.07B |
$0.43B |
13.99% |
| 2015-03-31 |
$3.09B |
$0.44B |
14.06% |
| 2014-12-31 |
$3.09B |
$0.41B |
13.41% |
| 2014-09-30 |
$3.06B |
$0.39B |
12.59% |
| 2014-06-30 |
$3.03B |
$0.38B |
12.46% |
| 2014-03-31 |
$3.00B |
$0.37B |
12.32% |
| 2013-12-31 |
$2.95B |
$0.35B |
11.95% |
| 2013-09-30 |
$2.91B |
$0.36B |
12.38% |
| 2013-06-30 |
$2.88B |
$0.28B |
9.63% |
| 2013-03-31 |
$2.84B |
$0.26B |
9.30% |
| 2012-12-31 |
$2.82B |
$0.25B |
9.00% |
| 2012-09-30 |
$2.79B |
$0.21B |
7.54% |
| 2012-06-30 |
$2.79B |
$0.28B |
9.89% |
| 2012-03-31 |
$2.79B |
$0.26B |
9.44% |
| 2011-12-31 |
$2.79B |
$0.27B |
9.54% |
| 2011-09-30 |
$2.77B |
$0.30B |
10.74% |
| 2011-06-30 |
$2.73B |
$0.29B |
10.72% |
| 2011-03-31 |
$2.68B |
$0.28B |
10.59% |
| 2010-12-31 |
$2.62B |
$0.26B |
10.06% |
| 2010-09-30 |
$2.58B |
$0.26B |
9.89% |
| 2010-06-30 |
$2.52B |
$0.23B |
9.17% |
| 2010-03-31 |
$2.42B |
$0.21B |
8.76% |
| 2009-12-31 |
$2.33B |
$0.20B |
8.38% |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$21.715B |
$11.479B |
|
Flavors & Fragrances is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. It has 4 business units: Nourish, Scent, Health & Biosciences and Pharma Solutions; comprising 3 platforms: Ingredients, Flavors & Food Designs. Ingredients provide texturizing solutions to the food industry, food protection solutions for food and beverage products, specialty soy & pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds & natural taste solutions, and value-added spices and seasoning ingredients. Food Designs offer savory solution products. Health & Biosciences includes, Health, Cultures & Food Enzymes, Home & Personal Care, Animal Nutrition, Grain Processing and Microbial Control, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Pharma Solutions produces cellulosics and alginates-based pharma excipients.
|
